Retinoic acid-inducible gene-I (RIG-I) recognizes viral dsRNA in the cytoplasm, and RIG-I-mediated signaling regulates antiviral type I IFN, and inflammatory chemokine production. Here, we tested the hypothesis that oral mucosal cell participation in host defense against viral infection via RIG-I. Methods: RIG-I expression was detected in immortalized oral keratinocytes (RT7), oral fibroblasts (GT1) using and RT-PCR and immunohistochemistry. RT7 and GT1 were exposed to dsRNA virus mimic Poly I:C-LMW/ LyoVec (PLV). Expression of IFN-β and CXCL10 via RIG-I was examined by Real-time RT-PCR and ELISA. Phosphorylation of IRF3 and STAT1 were detected by western blotting. Results: RT7 and GT1 constitutively expressed RIG-I in the cytoplasm. Furthermore, PLV increased IFN-β and CXCL10 productions in both RT7 and GT1 via RIG-I concurrent with phosphorylation of IRF3 and STAT1. PLV-induced CXCL10 production was attenuated by neutralization of IFN-β and blocking of IFN-α/β receptor (IFNAR), indicating primal IFN-β production via the RIG-I-IRF3 axis, which eventually induces CXCL10 production via the IFNAR -STAT1 axis. Conclusion: We propose that RIG-I in oral keratinocytes and fibroblasts may cumulatively develop hostdefense mechanisms against viral infection in oral mucosa.
Introduction
The innate immune system constitutes the first line of host defense against invading viruses. Viral signature patterns including viral DNA and RNA are recognized by both endosomal membrane and cytoplasmic receptors in various cell types [1] . Toll-like receptors Ohta et 
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Committee of Hiroshima University. A cytologic brush was spun in the buccal mucosa for 10 seconds in a single direction, while constant pressure was applied to the mucosa. The brush was then withdrawn, immediately plunged into the RNA preservative buffer (Ambion, Austin, TX, USA) at room temperature, and then frozen for later use.
Immunocytochemistry
Cells were seeded into 8 well-chamber slide (Matsunami Glass, Osaka, Japan) and fixed in 4% paraformaldehyde in PBS for 15 minutes, followed by permeabilization with 0.2% Triton X-100 in PBS for 5 minutes and incubation overnight with primary antibodies diluted in PBS containing 5% BSA. Next, the cells were washed and incubated with diluted Alexa Fluor secondary antibody (Invitrogen) for 1 hr. Vectashield anti-fade medium containing DAPI (Vector Laboratories, Burlingame, CA, USA) was used to mount the cells. Fluorescent and phase contrast images were acquired using a BZ-9000 microscope (KEYENCE, Osaka, Japan).
Small interfering RNA
A stealth small interfering RNA (siRNA) for RIG-I, and negative control siRNA were purchased from Invitrogen. RT7 and GT1 were transiently transfected with various combinations of the siRNAs using Lipofectamine® 2000 transfection reagent (Invitrogen), according to the manufacturer's recommendations.
RNA extraction, RT-PCR, and real-time PCR
The gene-specific oligonucleotide primers used for PCR analysis were as follows : RIG-I sense 5 '-AGG  AAA ACT GGC CCA AAA CT-3' and antisense 5'-TTT CCC CTT TTG TCC TTG TG-3', IFN-β sense 5'-TGC TCT GGC  ACA ACA GGT AG-3' and antisense 5'-GCT GCA GCT GCT TAA TCT CC-3', CXCL10 sense 5'-GCA GCT GAT TTG  GTG ACC ATC ATT GG-3' and antisense 5'-TGC AAG CCA ATT TTG TCC ACG TGT TG-3'. TLR3 sense 5'-AAA  TTG GGC AAG AAC TCA CAG G-3' and antisense 5'-GTG TTT CCA GAG CCG TGC TAA-3', MDA5 sense 5'-CTG  CTG CAG AAA ACA ATG GA-3' and antisense 5'-TGC CCA TGT TGC TGT TAT GT-3', LGP-2 sense 5'-ATG TGA  ACC CCA ACT TCT CG-3' and antisense 5'-CAA TGC TGC AGG AAG TCA AA-3' Total RNA was prepared from the cell lines using an RNeasy total RNA isolation Kit (Qiagen, Hilden, Germany). One-step RT-PCR was performed using an RT-PCR High Plus System (Toyobo, Osaka, Japan) according to the manufacturer's instructions. Single-stranded cDNA for RT-PCR and a quantitative real-time PCR template were synthesized using a First Strand cDNA Synthesis Kit (Amersham Biosciences, Uppsala, Sweden). The RT-PCR conditions for RIG-I were 1× (95°C, 15 minutes), 35× (95°C, 2 minutes; 55°C, 30 seconds; 72°C, 1 minute) and 1× (72°C, 7 minutes), and those for TLR3, MDA5, and LGP2 were 1× (95°C, 15 minutes), 30× (95°C, 2 minutes; 55°C, 30 seconds; 72°C, 1 minute) and 1× (72°C, 7 minutes), while those for β-actin were 1× (95°C, 15 minutes), 25× (95°C, 2 minutes; 55°C, 30 seconds; 72°C, 1 minute), and 1× (72°C, 7 minutes). Quantitative real-time PCR was performed using SYBR-Green Master Mix (Applied Biosystems, Carlsbad, CA, USA) for 40 cycles at 95°C for 15 seconds and 60°C for 60 seconds. Quantitative PCR analysis was performed using a CFX Connect Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA). Relative quantification of given mRNA levels among the samples was performed according to User Bulletin #2 (Applied Biosystems), with the results shown as the mean ± standard deviation from 3 independent experiments.
Cytokine determination
Cell culture supernatants were collected, and the concentration of IFN-β and CXCL10 were measured using an IFN-β ELISA kit (Fujirebio, Tokyo, JAPAN) and CXCL10 ELISA kit (R&D Systems), respectively, as previously described [6] .
Western blotting
Cells were harvested using a Mammalian Cell Lysis Kit (Sigma-Aldrich). Protein concentrations were determined using a protein assay kit (Bio-Rad Laboratories) and 25 μg of protein from each sample was separated on 10% SDS-polyacrylamide gels, then transferred to polyvinylidene fluoride membranes (Amersham Biosciences). After incubation with the specific antibody, immunoblots were labeled with the HRP-conjugated secondary antibody and developed using an ECL Advance Western Blotting Detection Kit (GE Healthcare Life Sciences, Tokyo, Japan). Image data were analyzed with an LAS 4000 mini imaging system (Fuji Film, Tokyo, Japan). 
Statistical analysis
Data were analyzed using Student's t-test or one-way analysis of variance (ANOVA), and the results are presented as the mean ± standard deviation.
Results

Oral keratinocytes and fibroblasts expressed RIG-I
To investigate the potential contribution of oral mucosal non-immune cells to innate antiviral response via RIG-I, we first examined whether oral keratinocytes and fibroblasts express RIG-I. RT-PCR results showed that pure keratinocytes and fibroblasts in cultures constitutively expressed RIG-I mRNA, whereas buccal mucosal cells derived from swabs variously expressed RIG-I (Fig. 1A) . RIG-I was detected in the cytoplasm of both RT7 and GT1 when analyzed by immunocytochemistry (Fig. 1B) , indicating that RIG-I was functional in those cells. Since the primary cells showed limited proliferative activity, we subjected immortalized oral keratinocytes and fibroblasts to the following analyses.
PLV induced IFN-β and CXCL10 in oral mucosal cells via RIG-I
We used poly I:C-LMW/LyoVec (PLV), a complex of low molecular weight poly I:C and the transfection reagent LyoVec as a potential RIG-I ligand [14] . IFN-β, is produced by nonimmune cells, such as fibroblasts infected with a virus, is a Type1 cytokine. Therefore, we focused on IFN-β as Type I IFN [15] . When exposed to PLV for 12 hrs, mRNA levels of IFN-β showed significant increases in both RT7 and GT1 ( Fig. 2A) . We also found that CXCL10 mRNA was dramatically induced by PLV in a dose-dependent manner (Fig. 2B ). To examine whether intercellular response predominantly functioned in transcribed dsRNA, we compared the effects of naked low molecular weight poly I:C (Poly I:C/LMW) and PLV, and found that PLV increased CXCL10 in comparison with Poly:IC LMW in both cells (Fig. 2C) .
To determine whether RIG-I was actually associated with the increase of IFN-β and CXCL10 in response to the possible ligand PLV, we performed siRNA-mediated knockdown were obtained as previously reported [13] . Total RNA was isolated from each cell line cultured to confluence then RT-PCR assays were performed for RIG-I and β-actin. (B) Expression of RIG-I protein in oral keratinocytes and fibroblasts. Green staining indicating RIG-I was observed in the cytoplasm of the cells. (Fig. 3A) . The production levels of both IFN-β and CXCL10 induced by PLV were specifically attenuated by siRNAs to RIG-I designed differently, indicating that RIG-I contributed to the PLV induced production of IFN-β and CXCL10 (Fig. 3 B) .
PLV activated IRF3 and STAT1 in oral mucosal cells
To elucidate which signaling pathway functioned in the induction of IFN-β and CXCL10, we evaluated the site-specific phosphorylation of IRF-3 and STAT1, which are transcriptional factors that activate transcription for IFN-β and CXCL10, respectively [16, 17] . Exposure to PLV markedly induced phosphorylation of IRF3 and STAT1 in both RT7 and GT1 (Fig. 4A) . Since site-specific phosphorylation of IRF3 is catalyzed by TBK1 and IKKε [18, 19] , the specific inhibitor of these kinases BX795 was tested. When exposed to PLV with increasing amounts of BX795, both RT7 and GT1 clearly showed a reduced level of PLV-dependent IFN-β and CXCL10 induction in a dose-dependent manner (Fig. 4B,C) . Similarly, the JAK inhibitor AG490, which prevents site-specific phosphorylation of STAT1 by this kinase, dramatically decreased PLV-induced CXCL10 production in both RT7 and GT1 in a dosedependent manner (Fig. 4C) . On the other hand, AG490 did not affect PLV-induced IFN-β in either cell type indicating that STAT1 was not responsible for PLV-induced INF-β production (Fig. 4B) . Knockdown of RIG-I in RT7 and GT1 confirmed that the phosphorylation of STAT1 in response to exposure to PLV, was dependent on RIG-I (Fig. 4D) .
PLV induced CXCL10 in oral mucosal cells via RIG-I-dependent IFN-β production
Although the best known activator to lead CXCL10 production is type II interferon, which activate STAT1 homodimer, type I interferon also has an ability to lead the activates [20] . Therefore, we examined whether recombinant IFN-β activated the production of CXCL10 with STAT1 phosphorylation in RT7 and GT1. Recombinant IFN-β induced CXCL10 production in both cells in a dose-dependent manner (Fig. 5A) , as well as phosphorylation of STAT1 (Fig. 5B) . To confirm the contribution of IFN-β to PLV-induced CXCL10 production, neutralizing antibodies to block IFN-β signaling were applied. Both the neutralizing antibody to IFN-β and the antagonistic antibody to IFN α/β receptor (IFNAR) attenuated PLV-induced CXCL10 production in RT7 and GT1 (Fig. 4C ).
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Discussion
RIG-I was previously characterized as a cytoplasmic pattern recognizing receptor (PRR) for the viral signature dsRNA that functions in signal type I IFN production against virus infection [4] . In RIG-I −/− mice, fibroblasts and dendritic cells failed to generate IFN-β upon RNA virus infection [21] . In addition, RIG-I was detected not only in fibroblasts and immune cells, but also in some epithelial cells in the colon, bronchi, and lungs [22] [23] [24] . The present study is the first to reveal that oral keratinocytes as well as oral fibroblasts constitutively express functional RIG-I in their cytoplasm.
Synthetic poly I:C/LyoVec, a complex of synthetic poly I:C and the transfection reagent LyoVec functions efficiently as an agonist to cytoplasmic PRRs rather than transmembrane PRR (i.e., TLR3). Among the potent RNA helicase PRRs, RIG-I recognizes dsRNA with a lowmolecular weight (up to 1 kb), whereas another intracellular PRR MDA5, which triggers (1 or 2µM) or AG490 (1 or 10µM) for 1 hr, then exposed to PLV (500 ng/mL) for 12 hrs. IFN-β mRNA levels are shown as relative to β-actin, used as an internal control, and the values are presented as the mean ± standard deviation of 3 independent experiments. #Significant decrease as compared with PLV alone (Student's t-test: p < 0.05). (C) Effects of IRF3 and JAK/STAT inhibition on PLV-induced CXCL10 expression in RT7 and GT1. Cells were preincubated with BX795 (1 or 2µM) or AG490 (1 or 10µM) for 1 hr, then exposed to PLV (500 ng/mL) for 24 hrs, after which the levels of IFN-β and CXCL10 in culture supernatants were determined by ELISA. Data are shown as the mean±standard deviation of 3 independent experiments. # Significant decrease as compared with PLV alone (Student's t-test: p < 0.05). (D) Effects of siRNA for RIG-I on PLV-induced STAT1 activation in RT7 and GT1. Cells were transiently transfected with the indicated combinations of the siRNA for RIG-I and the negative control siRNA for 48 hrs, then exposed to PLV (500ng/mL) for 6 hrs. Extracts of cells were subjected to SDS-PAGE. We examined STAT1 activation by western blotting analysis with antibodies against phospho-specific STAT1, and total STAT1. mitochondrial IPS1-dependent innate immune signaling response, detects long dsRNA (more than 2 kb) [25] . As expected, based on our findings of RIG-I expression in both mRNA and protein of RT7 and GT1, low molecular weight poly I:C/LyoVec dramatically increased the levels of IFN-β and CXCL10, while PLV-induced IFN-β and CXCL10 levels were decreased Ohta et 
by knockdown of RIG-I in those cells. Together, our results suggest that oral keratinocytes and fibroblasts are involved in host defense responses against virus invasion via RIG-I. RIG-I acts as a major RNA viral sensor in fibroblasts [26] . TLR3 is localized in the endosome membrane, and has been shown to recognize the synthetic dsRNA analogue naked poly I:C. However, TLR3-/-mouse embryonic fibroblasts exhibit normal IFN response with viral infections [20] . MDA5 is a RIG-I-like receptor that senses cytoplasmic viral RNA and induces antiviral responses via the adaptor protein MAVS [25] , and MDA5-/-MEFs were shown to produce comparable amounts of IFN-β in response to transcribed dsRNAs, whereas RIG-I -/-MEFs did not produce detectable amounts of IFN-β in response to those [20] . In the present study, PLV (transcribed Poly I:C/LMW) increased CXCL10 in comparison with Poly I:C/LMW for TLR3 agonists in both types of cells. Especially in RT7, the increase in CXCL10 by PLV was dramatically different from that by Poly I:C/LMW. Furthermore, transfection with siRNA for MDA5 decreased the level of PLV-induced CXCL10 to a much lower level than siRNA for RIG-I in GT1, but not RT7 (data not shown). Although, other extracellular and intracellular PRRs may account for the incomplete suppression of cytokine production in the RIG knockdown experiment (Fig. 3B) , intercellular response via RIG-I was shown to have an anti-viral response in oral keratinocyets as well as oral fibroblasts. expression in RT7 and GT1. Cells were exposed to various concentrations of IFN-β for 12 hrs, after which the levels of CXCL10 in culture supernatant were measured by ELISA. Data are shown as the m e a n ± s t a n d a rd deviation of 3 independent experiments. *Significant increase as compared with PLV alone (Student's t-test: p < 0.05). (B) Effects of IFN-β on STAT1 phosphorylation in RT7 and GT1. Cells were exposed to PLV (500 ng/mL) for the indicated durations. Cell extracts were subjected to SDS-PAGE and western blotting with antibodies against phospho-specific STAT1, and total STAT1. (C) Effects of blocking antibodies against IFN-β and IFN-α/β receptor on PLV-induced CXCL10 expression in RT7 and GT1. Cells were pre-incubated with the IFN-β antibody, IFN-α/β receptor (IFNAR) antibody, and anti-rabbit IgG (10 or 50 µg/mL) for 1 hr, then exposed to PLV (500 ng/mL) for 24 hrs, after which the levels of CXCL10 in culture supernatant were measured by ELISA. Data are shown as the mean ± standard deviation of 3 independent experiments. # Significant decrease as compared with PLV alone (Student's t-test: p < 0.05).
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CXCL10 is an inflammatory chemokine that mainly recruits activated T cells and NK cells to sites of infection or inflammation [7] . CXCL10 expression is significantly induced and plays a critical role in host defense with a variety of viral infections and CXCL10-knockout mice have shown a decreased ability to control viral infections, as well as impaired T cell recruitment and activation [27] . Some investigators have reported that RIG-I is associated with induction of CXCL10 in human bronchial epithelial cells [17, 28] and fibroblast-like synoviocytes [29] . In agreement with those findings, we noted that RIG-I in oral keratinocytes and fibroblasts regulated CXCL10 production as an intracellular receptor of dsRNA. On the other hand, it has been reported that RIG-I regulating of CXCL10 is associated with T cell mediated-autoimmune disease, such as rheumatoid arthritis [29] . Anti-virus responses via RIG-I may attract T-cells to the site of infection through CXCL10 to develop T cell-mediated oral inflammation.
STAT1 is a key mediator of cytokine-induced gene expression under type II interferon [20] , and activated STAT1 directly regulates the expression of CXCL10 [30] . In the present study, RIG-I-mediated signal transduction resulted in CXCL10 production via the IFNARSTAT1axis in both RT7 and GT1, which was initiated by INF-β production in response to PLV exposure, while PLV-induced CXCL10 in RT7 was strongly inhibited by blocking IFNAR and the TBK1 inhibitor in comparison with that in GT1. Therefore, regulation of PLV-induced CXCL10 via RIG-I may be dependent on IRF3/IFN-β in oral keratinocytes, while a parallel signaling pathway independent of the RIG-I/IRF3/IFN-β axis may exist in oral fibroblasts for CXCL10 production.
In conclusion, this is the first demonstration that 1) Oral keratinocyte as well as oral fibroblast expressed functional RIG-I 2) RIG-I recognized virus mimic ds RNA to produce IFN-β and CXCL10 3) RIG-I was essential for activation of IRF3 and STAT1 in response to virus mimic ds RNA 4) RIG-I-IRF3 axis shaped the autocrine IFN-β-STAT1 axis to produce CXCL10. Taken together, our results indicate that RIG-I in oral keratinocytes and fibroblasts may cumulatively participate in host-defense against viral infection in oral mucosa.
